SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
9 references·0 citing·30 second hop
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study (2019)The availability, prices and affordabilit…Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases (2017)Baseline assessment of WHO’s …Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases (2016)Of markets and rights: Discou…Gaps in universal health coverage in Malawi: A qualitative study in rural communities (2014)Gaps in universal health cove…Essential Medicines Are More Available than Other Medicines around the Globe (2014)Essential Medicines Are More …The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries (2013)The Availability, Pricing and…Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries (2012)Mapping the availability, pri…Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data (2010)Availability, price and affor…Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Medicine prices, availability…Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia (2007)Evaluating Drug Prices, Avail…Qualitative Research Methods (2006)The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries (2019)Qualitative Research Methods (2021)Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022)Qualitative research & evaluation methods (2002)Overcoming barriers to health service access: influencing the demand side (2004)Health systems financing and the path to universal coverage (2010)Developing attributes and attribute-levels for a discrete choice experiment on micro health insurance in rural Malawi (2014)The effects of medicines availability and stock-outs on household’s utilization of healthcare services in Dodoma region, Tanzania (2019)Strengthening the Health System as a Strategy to Achieving a Universal Health Coverage in Underprivileged Communities in Africa: A Scoping Review (2022)Projections of Global Mortality and Burden of Disease from 2002 to 2030 (2006)The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries (2007)Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries (2020)Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries (2011)Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology (2019)Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability (2020)Selection and Use of Essential Medicines (2023)International Public Health: Diseases, Programs, Systems, and Policies (2001)Grand challenges in global mental health (2011)Health care utilization and outpatient, out-of-pocket costs for active convulsive epilepsy in rural northeastern South Africa: a cross-sectional Survey (2016)Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration (2013)Insulin prices, availability and affordability in 13 low-income and middle-income countries (2019)Trade, TRIPS, and pharmaceuticals (2009)Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved? (2012)THE WORLD MEDICINES SITUATION 2011 (2011)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Essential medicines for universal health coverage (2016)Strengthening of accountability systems to create healthy food environments and reduce global obesity (2015)The prospective impact of food pricing on improving dietary consumption: A systematic review and meta-analysis (2017)The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review (2018)
this work references cited by second hop

References

  • 2008Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis926 cited
  • 2016Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases533 cited
  • 2007Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia201 cited
  • 2010Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data180 cited
  • 2017Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases159 cited
  • 2014Gaps in universal health coverage in Malawi: A qualitative study in rural communities140 cited
  • 2013The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries135 cited
  • 2014Essential Medicines Are More Available than Other Medicines around the Globe126 cited
  • 2012Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries115 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work